
About Aigen Therapeutics Private Limited
Data last updated:
Aigen Therapeutics Private Limited is a private limited company based in Gurgaon, Haryana, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 08 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U74994HR2019PTC080219.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anup Kumar Gupta and Yash Pal Chaddah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 84 Sector 9A, Gurgaon, Haryana, India – 122001.
The company is associated with 1 brand: AIGen Therapeutics.
For more details, the company can be reached via its website aigenthera.com.
Recognitions & Rankings of Aigen Therapeutics
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address84 Sector 9A, Gurgaon, Haryana, India – 122001
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Aigen Therapeutics Private Limited
Aigen Therapeutics operates one associated brand: AIGen Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| AI-driven company developing therapies for genetic and infectious diseases using advanced algorithms. | aigenthera.com |
Financials of Aigen Therapeutics Private Limited FY 2025 filings available
Financial Statement Summary of Aigen Therapeutics Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Aigen Therapeutics Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aigen Therapeutics are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Aigen Therapeutics Private Limited
Aigen Therapeutics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anup Kumar Gupta | Director | 08 May 2019 | 7 Years 5 Months | Current |
| Yash Pal Chaddah | Director | 08 May 2019 | 7 Years 5 Months | Current |
Ownership and Shareholding of Aigen Therapeutics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aigen Therapeutics Private Limited
Aigen Therapeutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aigen Therapeutics Private Limited
Employment history and EPFO contributions of people linked to Aigen Therapeutics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aigen Therapeutics Private Limited
Aigen Therapeutics Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Deepak Khetarpal ceased to be Additional Director on 30 Nov 2021.
Credit Ratings, Litigation & Regulatory Alerts for Aigen Therapeutics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aigen Therapeutics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aigen Therapeutics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aigen Therapeutics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aigen Therapeutics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aigen Therapeutics Private Limited
Aigen Therapeutics is an active private limited company based in Gurgaon, Haryana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 08 May 2019 (7+ years old) and is registered under CIN U74994HR2019PTC080219.
Aigen Therapeutics has 2 current directors:
- Anup Kumar Gupta - Director
- Yash Pal Chaddah - Director
The CIN (Corporate Identification Number) of Aigen Therapeutics is U74994HR2019PTC080219. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aigen Therapeutics was incorporated on 08 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.
Deepak Khetarpal ceased to be Additional Director on 30 Nov 2021. Anup Kumar Gupta was appointed as Director on 08 May 2019. Yash Pal Chaddah was appointed as Director on 08 May 2019.
Yes, Aigen Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Aigen Therapeutics can be reached through the website aigenthera.com. Its registered office is in Gurgaon, Haryana, India.
The registered office of Aigen Therapeutics is at 84 Sector 9A, Gurgaon, Haryana, India – 122001.
Aigen Therapeutics has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.
Aigen Therapeutics operates in the life sciences industry, in the biotechnology segment.